强直性脊柱炎合并骨质疏松或骨量减少临床研究进展

doi:10.16150/j.1671-2870.2019.01.023

摘要/Abstract

中图分类号:

R593.23

钟驾云, 吴歆, 徐沪济. 强直性脊柱炎合并骨质疏松或骨量减少临床研究进展[J]. 诊断学理论与实践, 2019, 18(1): 109-112.

参考文献 29

[1]	中华医学会风湿病学分会. 强直性脊柱炎诊断及治疗指南[J]. 中华风湿病学杂志, 2010, 14(8):557-559.
[2]	Magrey MN, Lewis S, Asim Khan M, et al. Utility of DXA scanning and risk factors for osteoporosis in ankylosing spondylitis-A prospective study[J]. Semin Arthritis Rheum, 2016, 46(1):88-94.
[3]	Ulu MA, Batmaz Ī, Dilek B, et al. Prevalence of osteoporosis and vertebral fractures and related factors in patients with ankylosing spondylitis[J]. Chin Med J, 2014, 127(15):2740-2747.
[4]	孔维萍, 张卫, 陶庆文, 等.1 051例强直性脊柱炎患者骨密度分析[J]. 中国骨质疏松杂志, 2012, 18(11):1036-1041.
[5]	Wang DM, Zeng QY, Chen SB, et al. Prevalence and risk factors of osteoporosis in patients with ankylosing spondylitis: a 5-year follow-up study of 504 cases[J]. Clin Exp Rheumatol, 2015, 33(4):465-470.
[6]	Malochet-Guinamand S, Pereira B, Tatar Z, et al. Prevalence and risk factors of low bone mineral density in spondyloarthritis and prevalence of vertebral fractures[J]. BMC Musculoskelet Disord, 2017, 18(1):357.
[7]	Maas F, Spoorenberg A, van der Slik BPG, et al. Clinical Risk Factors for the Presence and Development of Vertebral Fractures in Patients With Ankylosing Spondylitis[J]. Arthritis Care Res (Hoboken), 2017, 69(5):694-702.
[8]	Thomsen K, Jepsen DB, Matzen L, et al. Is calcaneal quantitative ultrasound useful as a prescreen stratification tool for osteoporosis?[J]. Osteoporos Int, 2015, 26(5):1459-1475.
[9]	孙红杰, 丛树国, 李旭光, 等. 超声检查对强直性脊柱炎患者骨质疏松的评估[J]. 中国继续医学教育, 2016, 8(30):54-55.
[10]	中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017)[J]. 中华骨质疏松和骨矿盐疾病杂志, 2017, 10(5):413-443.
[11]	Ulu MA, Çevik R, Dilek B, et al. Comparison of PA spine, lateral spine, and femoral BMD measurements to determine bone loss in ankylosing spondylitis[J]. Rheumatol Int, 2013, 33(7):1705-1711.
[12]	Klingberg E, Lorentzon M, Göthlin J, et al. Bone microarchitecture in ankylosing spondylitis and the association with bone mineral density, fractures, and syndesmophytes[J]. Arthritis Res Ther, 2013, 15(6):R179.
[13]	Sayed S, Darweesh H, Fathy K, et al. Clinical significance of bone mineral density in Ankylosing Spondylitis patients: Relation to disease activity and physical function[J]. Egyptian Rheumatologist, 2015, 37(1):35-39.
[14]	Vasdev V, Bhakuni D, Garg MK, et al. Bone mineral density in young males with ankylosing spondylitis[J]. Int J Rheum Dis, 2011, 14(1): 68-73.
[15]	Grazio S, Kusiéc Z, Cvijetiéc S, et al. Relationship of bone mineral density with disease activity and functional ability in patients with ankylosing spondylitis: a cross-sectio-nal study[J]. Rheumatol Int, 2012, 32(9):2801-2808.
[16]	van der Weijden MA, van Denderen JC, Lems WF, et al. Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies[J]. Clin Rheumatol, 2011(4), 30(4):497-503.
[17]	Kisacik B, Tufan A, Kalyoncu U, et al. Mean platelet vo-lume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis[J]. Joint Bone Spine, 2008, 75(3):291-294.
[18]	Resorlu H, Resorlu M, Gokmen F, et al. Association between mean platelet volume and bone mineral density in patients with ankylosing spondylitis and diagnostic value of diffusion-weighted magnetic resonance imaging[J]. J Phys Ther Sci, 2015, 27(4):1137-1140.
[19]	Hinze AM, Louie GH. Osteoporosis Management in Ankylosing Spondylitis[J]. Curr Treat Options in Rheum, 2016, 2(4):271-282.
[20]	Zhang P, Li Q, Qi J, et al. Association between vitamin D receptor gene polymorphism and ankylosing spondylitis in Han Chinese[J]. Int J Rheum Dis, 2017, 20(10):1510-1516.
[21]	Cai G, Zhang X, Xin L, et al. Associations between vitamin D receptor gene polymorphisms and ankylosing spondylitis in Chinese Han population: a case-control study[J]. Osteoporos Int, 2016, 27(7):2327-2333.
[22]	谢建丽, 魏平, 王俊祥, 等. 维生素D在强直性脊柱炎骨代谢中的作用研究[J]. 中华风湿病学杂志, 2013, 17(11):771-774.
[23]	Khabbazi A, Noshad H, Gafarzadeh S, et al. Alendronate Effect on the Prevention of Bone loss in Early Stages of Ankylosing Spondylitis: A Randomized, Double-Blind, Placebo-Controlled Pilot Study[J]. Iran Red Crescent Med J, 2014, 16(6):e18022.
[24]	Li G, Lv CA, Tian L, et al. A retrospective study of alendronate for the treatment of ankylosing spondylitis[J]. Medicine, 2018, 97(20): e10738
[25]	Kang K Y, Lee K Y, Kwok S K, et al. The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis[J]. Joint Bone Spine, 2011, 78(2):188-193.
[26]	Dubrovsky AM, Lim MJ, Lane NE, et al. Osteoporosis in Rheumatic Diseases: Anti-rheumatic Drugs and the Skeleton[J]. Calcif Tissue Int, 2018, 102(5):607-618.
[27]	Haroon NN, Sriganthan J, Al Ghanim N, et al. Effect of TNF-alpha inhibitor treatment on bone mineral density in patients with ankylosing spondylitis: a systematic review and meta-analysis[J]. Semin Arthritis Rheum, 2014, 44(2):155-161.
[28]	Li H, Li Q, Chen X, et al. Anti-tumor Necrosis Factor Therapy Increased Spine and Femoral Neck Bone Mi-neral Density of Patients with Active Ankylosing Spondylitis with Low Bone Mineral Density[J]. J Rheumatol, 2015, 42(8):1413-1417.
[29]	van der Weijden MA, van Denderen JC, Lems WF, et al. Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures: Results of a Prospective Observational Cohort Study[J]. J Rheumatol, 2016, 43(4):758-764.

强直性脊柱炎合并骨质疏松或骨量减少临床研究进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 29

相关文章 15

编辑推荐

Metrics

本文评价

[1]	刘欣, 綦才辉, 王振竞, 吕娜, 王少婷, 王淑萍. 胰高血糖素样肽-1激动剂Exendin-4 刺激小鼠胚胎成骨细胞前体细胞MC3T3-E1的转录组学体外研究[J]. 诊断学理论与实践, 2022, 21(03): 367-373.
[2]	中华医学会内分泌学分会. 新型冠状病毒肺炎疫情下骨质疏松症管理专家建议[J]. 诊断学理论与实践, 2022, 21(02): 133-135.
[3]	杜艳萍, 程群. 骨质疏松症使用甲状旁腺激素类似物和双膦酸盐序贯治疗的机制及策略[J]. 诊断学理论与实践, 2020, 19(03): 219-224.
[4]	汪纯. 原发性骨质疏松症发病及诊治的现状和展望[J]. 诊断学理论与实践, 2020, 19(03): 209-213.
[5]	吴歆, 徐沪济. 应关注强直性脊柱炎患者身心健康、生活质量和易被忽视的骨质疏松[J]. 诊断学理论与实践, 2019, 18(1): 113-116.
[6]	卢红娟, 吴歆, 周凌, 赵娟, 徐沪济. 强直性脊柱炎合并系统性红斑狼疮病例报告1例[J]. 诊断学理论与实践, 2018, 17(03): 341-343.
[7]	何文涛, 余学锋. 糖尿病性骨质疏松发病情况及机制新认识[J]. 诊断学理论与实践, 2018, 17(01): 5-10.
[8]	陈凌, 钱锋, 叶玲英, 林丽, 吴歆, 李梦梦, 刘晓, 张志国, 张倜, 王赓, 徐沪济,. 抗CD74抗体不是汉族人群强直性脊柱炎患者的血清标志物[J]. 诊断学理论与实践, 2015, 14(04): 338-342.
[9]	宋婧, 卢红娟, 赵娟, 彭华, 吴歆, 徐沪济,. 强直性脊柱炎患者疾病活动度与睡眠障碍的相关性研究[J]. 诊断学理论与实践, 2015, 14(04): 343-347.
[10]	徐沪济, 吴歆, 宋婧,. 强直性脊柱炎免疫遗传学致病机制进展的认识[J]. 诊断学理论与实践, 2014, 13(03): 232-236.
[11]	赵东宝, 高颖, 贺玲玲,. 骨关节炎与骨质疏松症关系的再认识[J]. 诊断学理论与实践, 2014, 13(03): 237-239+241+240.
[12]	王筱婧, 陈瑛, 郁静嘉, 焦培林, 孙立昊, 陶蓓, 宣言, 刘建民, 王卫庆, 赵红燕,. 血清骨钙素水平与绝经后女性2型糖尿病患者骨密度的关系[J]. 诊断学理论与实践, 2014, 13(01): 68-71.
[13]	高利红, 庞小芬, 王培霞,. 阿仑膦酸钠及仙灵骨葆对OPG基因敲除小鼠骨骼肌的影响[J]. 诊断学理论与实践, 2013, 12(02): 205-209.
[14]	张伟滨,. 骨质疏松性骨折的外科认识[J]. 诊断学理论与实践, 2012, 11(01): 11-14.
[15]	章振林,. 骨质疏松症的诊断和鉴别诊断[J]. 诊断学理论与实践, 2012, 11(01): 19-20.